ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,435,605 | +200.3% | 68,887 | +245.1% | 0.14% | +174.5% |
| Q2 2023 | $478,018 | -9.8% | 19,959 | -29.1% | 0.05% | -17.7% |
| Q1 2023 | $529,764 | +39.4% | 28,149 | +18.0% | 0.06% | +10.7% |
| Q4 2022 | $379,899 | -20.3% | 23,863 | -18.1% | 0.06% | +16.7% |
| Q3 2022 | $476,747 | +140.8% | 29,141 | +107.1% | 0.05% | +84.6% |
| Q2 2022 | $198,000 | -17.5% | 14,070 | +42.1% | 0.03% | -52.7% |
| Q1 2022 | $240,000 | +3.0% | 9,901 | -1.0% | 0.06% | 0.0% |
| Q4 2021 | $233,000 | – | 9,999 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |